Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations - KIVIRID

Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations

Authors: Bernd Schnabl, Christopher J. Damman, Rotonya M. Carr

Published: 2025-03-31

DOI: 10.1172/jci186423

Source: Full article

Abstract

No abstract found.